Portal de Periódicos da CAPES

Antigenic and Molecular Structure of the Mite Allergen Der p 2

1997; Karger Publishers; Volume: 113; Issue: 1-3 Linguagem: Inglês

10.1159/000237517

1423-0097

Alisa M. Smith, Ernesto Akio Taketomi, Geoffrey A. Mueller, Gordon S. Rule, David C. Benjamin, Martin D. Chapman,

Food Allergy and Anaphylaxis Research

Research Articles| September 04 2009 Antigenic and Molecular Structure of the Mite Allergen Der p 2 Subject Area: Immunology and Allergy Alisa M. Smith; Alisa M. Smith aAsthma and Allergic Diseases Center and Departments of Search for other works by this author on: This Site PubMed Google Scholar Ernesto A. Taketomi; Ernesto A. Taketomi aAsthma and Allergic Diseases Center and Departments of Search for other works by this author on: This Site PubMed Google Scholar Geoffrey A. Mueller; Geoffrey A. Mueller cBiochemistry, University of Virginia School of Medicine, Charlottesville, Va., USA Search for other works by this author on: This Site PubMed Google Scholar Gordon S. Rule; Gordon S. Rule cBiochemistry, University of Virginia School of Medicine, Charlottesville, Va., USA Search for other works by this author on: This Site PubMed Google Scholar David C. Benjamin; David C. Benjamin bMicrobiology and Search for other works by this author on: This Site PubMed Google Scholar Martin D. Chapman Martin D. Chapman aAsthma and Allergic Diseases Center and Departments of Search for other works by this author on: This Site PubMed Google Scholar Int Arch Allergy Immunol (1997) 113 (1-3): 99–101. https://doi.org/10.1159/000237517 Article history Published Online: September 04 2009 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Alisa M. Smith, Ernesto A. Taketomi, Geoffrey A. Mueller, Gordon S. Rule, David C. Benjamin, Martin D. Chapman; Antigenic and Molecular Structure of the Mite Allergen Der p 2. Int Arch Allergy Immunol 31 December 1997; 113 (1-3): 99–101. https://doi.org/10.1159/000237517 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsInternational Archives of Allergy and Immunology Search Advanced Search Article PDF first page preview Close Modal Keywords: Dermatophagoides pteronyssinus, Antigenic determinant, IgE antibody, Mutagenesis, Antigenic variants, Tertiary structure 1997Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.